CEO of Raygent Associates
Contributor's Links: Raygent

Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 35 years executive experience including Abbott and JNJ and has been involved three successful start-ups. Before starting Raygent and other companies he was also a ... more

ALL CONTRIBUTIONS

Large Cap Biopharmaceutical Companies-Metrics And Valuations…
The IBB is at $122.69 near the 52 week high but short of 5 year high of $132.53 from Jy ’15.
Read
Biotech Reversal Off 2020 Bottom But Within Trading Range
Biotech stocks reversed from a bearish trend last week from a 1/31/20 short-term bottom.
Read
New Buy Ideas For 2020: Glaukos Corporation (GKOS)
Glaukos new products are rolling out in 2020 so there is revenue and earnings risk because of new technology and competition.
Read
Biotech Sector Watch: After JPMorgan Conference
It was only a modest one week drop of 1% in the S&P-500 but investors seemed to be shocked that the run ebbed. The reason for the loss of momentum is not yet clear but ostensibly it was concerns about the coronavirus.
Read
Geopolitical Uncertainty Curbs Biotech Stock Gains
The strong end of year biotech rally was stalled through lackluster holiday trading now with geopolitical uncertainty on the news front.
Read
Biotech Stocks Make Q4 Comeback In 2019: Our Calls Were Excellent
The biotech sector was virtually flat on 10/3/ 2019 and took off from there to give 30% gains in the XBI.
Read

Comments

Latest Comments
Regulatory News For Rare Disease Products - Hot Stocks: BLUE, ICPT, SRPT
4 years ago

Getting trial information and following them is the hard part as it takes too much time. Just sett up the stocks in a Yahoo portfolio and track daily. The WEB site of the Company usually lets you know if trial results are coming in and when.

In this article: BLUE, ICPT, SRPT
Biotech Buzz Is Broken
4 years ago

Here is the YTD for KITE down 4.7%:

www.google.com/finance

In this article: JUNO, KITE, GILD, REGN
2015 Biotech Stock Preview: Rhythms Of The “PermaBull”
5 years ago

prefer a fund like FBIOX but XBI will work when the market heats up

In this article: XLV, FBT, FBIOX, GILD
1 to 3 of 3 comments

STOCKS I FOLLOW

ABAX ABAXIS Inc.
ALXN Alexion Pharmaceuticals, Inc.
AMRI Albany Molecular Research, Inc.
CBST Cubist Pharmaceuticals Inc.
GPRO GoPro, Inc.
QDEL Quidel Corporation

TWEETS

PERSONAL BLOG

Latest Posts
Biotech Investing Strategy For 2020: Part I… Update-1 Jan 24
We remain on hold for taking on new positions. Biotech and healthcare stocks have made nice gains so let’s get through the earnings cycle.
Asco Rally Fizzles: The Nascent Rally In Biotech Stocks Fades
ASCO Rally Fizzles Two Weeks ahead of May 31-June 4 Meeting: XBI down 0.9% to $83.

Work Experience

CEO
Raygent Associates
January 1990 - Present (30 years 7 months)
Biotechnology Intelligence www.raygent.com

Education

Penn State University
BS
Biochemistry
Rutgers University
MBA
Business

Publications